Mitophagy: A promising therapeutic target for neuroprotection during ageing and age‐related diseases
British Journal of Pharmacology · 2023-06 · 180 (12) · 1542-1561
DOI: 10.1111/bph.16062 ↗At a glance
Übersichtsarbeit in British Journal of Pharmacology, published online on 2023-03-14. Written by Ela Mishra and 1 co-authors. Institution: Biochemistry and Molecular Biology Laboratory, Centre of Advanced Study, Department of Zoology, Institute of Science, Banaras Hindu University, Varan…. Major MEDLINE topics: Mitophagy, Alzheimer Disease. Cited 73 times so far (Crossref); 175 references. Funded by: Indian Council of Medical Research.
Abstract (original language)
Mitochondria and mitochondria‐mediated signalling pathways are known to control synaptic signalling, as well as long‐lasting changes in neuronal structure and function. Mitochondrial impairment is linked to synaptic dysfunction in normal ageing and age‐associated neurodegenerative ailments, including Parkinson's disease (PD) and Alzheimer's disease (AD). Both proteolysis and mitophagy perform a major role in neuroprotection, by maintaining a healthy mitochondrial population during ageing. Mitophagy, a highly evolutionarily conserved cellular process, helps in the clearance of damaged mitochondria and thereby maintains the mitochondrial and metabolic balance, energy supply, neuronal survival and neuronal health. Besides the maintenance of brain homeostasis, hippocampal mitophagy also helps in synapse formation, axonal development, dopamine release and long‐term depression. In contrast, defective mitophagy contributes to ageing and age‐related neurodegeneration by promoting the accumulation of damaged mitochondria leading to cellular dysfunction. Exercise, stress management, maintaining healthy mitochondrial dynamics and administering natural or synthetic pharmacological compounds are some of the strategies used for neuroprotection during ageing and age‐related neurological diseases. The current review discusses the impact of defective mitophagy in ageing and age‐associated neurodegenerative conditions, the underlying molecular pathways and potential therapies based on recently elucidated mitophagy‐inducing strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Biochemistry and Molecular Biology Laboratory, Centre of Advanced Study, Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, India.
Funding
- Indian Council of Medical Research
Cite
APA
Mishra, E., & Thakur, M. K. (2023). Mitophagy: A promising therapeutic target for neuroprotection during ageing and age‐related diseases. British Journal of Pharmacology, 180(12), 1542-1561. https://doi.org/10.1111/bph.16062
Vancouver
Mishra E, Thakur MK. Mitophagy: A promising therapeutic target for neuroprotection during ageing and age‐related diseases. British Journal of Pharmacology. 2023;180(12):1542-1561. doi:10.1111/bph.16062
BibTeX
@article{Mishra2023,
author = {Mishra, Ela and Thakur, Mahendra Kumar},
title = {Mitophagy: A promising therapeutic target for neuroprotection during ageing and age‐related diseases},
journal = {British Journal of Pharmacology},
year = {2023},
volume = {180},
number = {12},
pages = {1542--1561},
doi = {10.1111/bph.16062}
}
EUVIMED